Navigation Links
Genetic pattern that predicts leukemia relapse discovered

A genetic pattern that predicts the likelihood of relapse in patients with one of the most aggressive forms of childhood leukemia has been discovered. Researchers publishing in the open access journal Molecular Cancer have identified a consistent pattern in five genes that has the potential to enable doctors to identify which patients would benefit from more aggressive treatment when first diagnosed with T-cell acute lymphoblastic leukemia (T-ALL).

Co-author Dr Alex Beesley of Perth's Telethon Institute for Child Health Research said "While up to 80% of children with T-ALL achieve complete remission, there are around 20% who relapse and whose prognosis can be very poor," Dr Beesley said. "In this study, we found a consistent pattern in the expression of five genes in patients that relapse. Importantly, this pattern was found to hold true across multiple patient cohorts, the first time that such a robust gene signature of this kind has been found for T-ALL. This gene signature would enable patients with T-ALL to be classified according to risk at the time of diagnosis."

Dr Beesley said the discovery had significant potential to improve outcomes for patients at high risk of relapse. "Patients identified using these markers could potentially be treated with more aggressive therapies from the outset to give them the best hope of achieving complete remission."

The research team analyzed bone marrow samples from children treated under the international Children's Oncology Group (COG) protocols.

They used gene-profiling (microarray) technology to model a five-gene classifier that accurately predicted clinical outcome in a cohort of 50 T-ALL patients. The five-gene classifier was further tested against three independent cohorts of T-ALL patients, using two different techniques (either quantitative RT-PCR or microarray gene expression), and could predict patients with significantly adverse clinical outcome in each.

Dr Beesley said the study also provided clues to the biological mechanisms leading to relapse in T-ALL, which could ultimately identify potential targets for new therapies to the disease.

T-ALL affects approximately 15% of newly diagnosed pediatric leukemia patients. The prognostic potential of the gene markers identified from this research will now be investigated as part of a large international Children's Oncology Group study of T-ALL patients undergoing the latest therapy.


Contact: Charlotte Webber
BioMed Central

Related medicine news :

1. Resveratrol Supplement Company RevGenetics Welcomes New Chief Science Officer
2. Genetic Variants Tied to MS, Study Finds
3. UT Southwestern participates in nationwide study offering free lung tumor genetic testing
4. Genetic Research Sheds Light on Chronic Pain
5. High doses of antioxidant supplements induce stem cell genetic abnormalities
6. New research about human genetic diseases and human development
7. Genetics, Psychology May Trigger ADHD
8. Plant pathogen genetically tailors attacks to each part of host, say Stanford researchers
9. Study finds changes in fetal epigenetics throughout pregnancy
10. Lab that probes genetic clues to disease is poised for major expansion
11. Single Genetic Factor Key to Cardiovascular System
Post Your Comments:
(Date:11/30/2015)... Viejo, CA (PRWEB) , ... November 30, 2015 , ... ... Cut Pro X . Choose from scrolling web-styled transitions to wipes with blur ... colors, transition direction and more. Seamlessly transition from one clip to the next ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... and Attendance/Workforce Management cloud-based solutions, announced today that it has renewed the ... the Application Development, demonstrating a “best-in-class” ability and commitment to meet Microsoft’s ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... healthcare professionals worldwide today released the results of a survey of educational needs ... and Africa found a growing global demand for high quality online and face-to-face ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... to announce their strategic partnership at the Radiological Society of North America ... and Winscribe, global providers of cutting-edge dictation and speech-enabled documentation software, announced ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announce their strategic partnership at the Radiological Society of North America (RSNA) ... global providers of cutting-edge dictation and speech-enabled documentation software, announced their partnership ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
(Date:11/30/2015)... Mexico Healthcare and Life Sciences Report 2015 . ... --> Pharmaboardroom releases its new 98-page Mexico Healthcare and ... , a country of over 122 million people. --> ... people. --> It offers companies, investors, policymakers, and stakeholders ... the second largest pharma and healthcare market in Latin ...
(Date:11/30/2015)... and REHOVOT, Israel , ... specialty pharmaceutical company focused on acquiring and developing innovative ... announced the appointment of Keith A. Katkin ... Gregory J. Flesher , chief executive officer for ... building successful organizations.  As chairman, he will be able ...
Breaking Medicine Technology: